BCL2 and B-cell chronic lymphocytic leukemia: Mechanisms of resistance to venetoclax have been identified in G101V-mutated Bcl-2 proteins in CLL patients [132], thus emphasizing the need to persevere in research of Bcl-2 inhibitors.